Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.570
-0.160 (-4.29%)
Jul 9, 2026, 2:58 PM EDT - Market open
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $237.88 million as of July 9, 2026. Its market cap has decreased by -38.71% in one year.
Market Cap
237.88M
Enterprise Value
-77.57M
1-Year Change
-38.71%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $237.88M, a decrease of -21.14%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 237.88M | -68.12% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 259.67M |
| AC Immune | 248.99M |
| Anavex Life Sciences | 246.51M |
| Invivyd | 245.70M |
| Orchestra BioMed Holdings | 244.31M |
| ProQR Therapeutics | 242.72M |
| Sol-Gel Technologies | 242.30M |
| Codexis | 241.78M |